 SAN DIEGO and SUZHOU, China, Feb. 08, 2022 GLOBE NEWSWIRE -- Adagene Inc. Adagene Nasdaq: ADAG, a company transforming the discovery and development of novel antibody-based therapies, today announced that members of the companys management will participate in one-on-one investor meetings and provide a corporate update at the SVB Leerink 11th Annual Global Healthcare Conference, to be held virtually February 14-18, 2022. 